$1.02 Billion is the total value of SECTORAL ASSET MANAGEMENT INC's 56 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 9.4% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
MRK | Buy | MERCK & CO INC | $57,740,000 | +34.9% | 925,170 | +24.5% | 5.67% | +28.2% |
PFE | Buy | PFIZER INC | $57,366,000 | +36.6% | 1,693,707 | +42.1% | 5.63% | +29.9% |
CELG | Buy | CELGENE CORP | $50,396,000 | +22.6% | 482,118 | +15.7% | 4.95% | +16.6% |
LLY | Buy | ELI LILLY & CO | $48,752,000 | +16.8% | 607,427 | +14.6% | 4.79% | +11.1% |
MDT | Buy | MEDTRONIC PLC | $45,035,000 | +22.0% | 521,241 | +22.5% | 4.42% | +16.0% |
GILD | Buy | GILEAD SCIENCES INC | $41,472,000 | +4.4% | 524,165 | +10.1% | 4.07% | -0.7% |
PTLA | Buy | PORTOLA PHARMACEUTICALS | $32,230,000 | +11.1% | 1,419,208 | +15.4% | 3.16% | +5.6% |
SHPG | Buy | SHIRE PLCsp adr | $32,199,000 | +17.9% | 166,093 | +11.9% | 3.16% | +12.1% |
ACHC | Buy | ACADIA HEALTHCARE | $28,579,000 | +7.3% | 576,769 | +20.0% | 2.80% | +2.0% |
TDOC | Buy | TELADOC INC | $28,190,000 | +20.2% | 1,539,618 | +5.1% | 2.77% | +14.2% |
CI | New | CIGNA CORP | $28,029,000 | – | 215,080 | +100.0% | 2.75% | – |
GBT | Buy | GLOBAL BLOOD THERAPEUTICS | $23,775,000 | +45.2% | 1,031,449 | +4.5% | 2.33% | +38.0% |
ISRG | Buy | INTUITIVE SURGICAL INC | $20,523,000 | +61.0% | 28,314 | +46.9% | 2.02% | +53.1% |
NVO | Buy | NOVO-NORDISK ASadr | $18,523,000 | +59.3% | 445,375 | +106.0% | 1.82% | +51.4% |
OPHT | Buy | OPHTHOTECH CORP | $17,961,000 | +139.8% | 389,363 | +165.2% | 1.76% | +127.8% |
ALDR | Buy | ALDER BIOPHARMACEUTICALS | $17,601,000 | +34.2% | 537,121 | +2.3% | 1.73% | +27.6% |
COLL | Buy | COLLEGIUM PHARMACEUTICAL | $13,595,000 | +289.7% | 705,845 | +139.8% | 1.34% | +270.8% |
WMGI | Buy | WRIGHT MED GROUP N V | $12,388,000 | +94.4% | 505,005 | +37.6% | 1.22% | +84.8% |
NUVA | Buy | NUVASIVE INC | $11,996,000 | +20.8% | 179,960 | +8.2% | 1.18% | +14.9% |
ARAY | Buy | ACCURAY INC | $11,814,000 | +175.6% | 1,854,625 | +124.6% | 1.16% | +161.9% |
ICPT | Buy | INTERCEPT PHARMACEUTICALS | $11,628,000 | +49.1% | 70,651 | +29.3% | 1.14% | +41.7% |
PTCT | Buy | PTC THERAPEUTICS I | $10,928,000 | +139.9% | 779,998 | +20.2% | 1.07% | +128.3% |
AERI | Buy | AERIE PHARMACEUTICALS | $9,405,000 | +504.4% | 249,200 | +181.9% | 0.92% | +473.3% |
MOH | Buy | MOLINA HEALTHCARE | $8,931,000 | +17.1% | 153,145 | +0.2% | 0.88% | +11.3% |
KITE | New | KITE PHARMA INC | $6,498,000 | – | 116,326 | +100.0% | 0.64% | – |
AMSG | Buy | AMSURG CORP | $6,474,000 | -13.4% | 96,560 | +0.2% | 0.64% | -17.6% |
TMH | Buy | TEAM HEALTH HOLDINGS | $6,042,000 | -15.5% | 185,560 | +5.5% | 0.59% | -19.8% |
AVXS | Buy | AVEXIS INC | $6,038,000 | +518.6% | 146,515 | +470.7% | 0.59% | +487.1% |
IART | Buy | INTEGRA LIFESCIENCE | $5,712,000 | +18.2% | 69,200 | +14.3% | 0.56% | +12.4% |
ADXS | Buy | ADVAXIS INC | $4,668,000 | +33.0% | 436,659 | +0.6% | 0.46% | +26.5% |
Buy | NEURODERM LTDordinar | $2,995,000 | +75.6% | 161,971 | +54.3% | 0.29% | +67.0% | |
AGIO | Buy | AGIOS PHARMACEUTICALS | $2,784,000 | +84.1% | 52,700 | +46.0% | 0.27% | +75.0% |
ACAD | Buy | ACADIA PHARMACEUTCALS | $1,778,000 | +85.2% | 55,897 | +89.0% | 0.18% | +76.8% |
ALNY | Buy | ALNYLAM PHARMACEUTICALS | $1,749,000 | +215.1% | 25,800 | +158.0% | 0.17% | +201.8% |
DBVT | New | DBV TECHNOLOGIESsp adr | $1,428,000 | – | 39,301 | +100.0% | 0.14% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-11-10
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
PFIZER INC | 35 | Q3 2023 | 6.3% |
MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
SEQUENOM INC | February 12, 2014 | ? | ? |
INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-14 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-12 |
SC 13G/A | 2023-02-13 |
SC 13G | 2023-02-13 |
13F-HR | 2023-02-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.